Plexus(NASDAQ) PLXS

Plexus helps companies design and build complex electronic products. They work with experts to create medical devices and aerospace equipment. Their services make it easier to get high-tech tools into the hands of users.

What They Build

• Healthcare and Life Sciences: Manufacturing and design services for medical tools; accounts for 44% of net sales in Q1 2026.
• Industrial: Production of automation and specialized commercial systems; accounts for 40% of net sales in Q1 2026.
• Aerospace and Defense: Electronics for mission-critical flight and security systems; accounts for 16% of net sales in Q1 2026.
• Aftermarket Services: Support solutions including product repair and maintenance; available across all market sectors.

Recent Strategic Moves

• Completed a reduction in workforce during the first quarter of fiscal 2025 to align costs in the AMER and EMEA regions.
• Board of Directors authorized a $100 million share repurchase program on May 14, 2025.
• Adopted global minimum tax standards in Q1 2026 across several international operating jurisdictions.

A Global Support Network

Plexus operates 27 facilities globally with a team of over 20,000 members. They utilize a complex business model to handle high product mix requirements for demanding regulatory environments.

The Financial Scorecard

• Net sales rose to $1.1 billion in Q1 2026, up 9.6% year-over-year.
• Net income reached $41.2 million in Q1 2026, up 10.5% from the previous year.
• Operating income grew to $54.5 million in Q1 2026, a 16.2% increase year-over-year.
• Free cash flow fell to negative $50.6 million in Q1 2026, down from positive $27.1 million in Q1 2025.
• Inventory levels increased to $1.3 billion as of January 3, 2026, to support new program ramps.

Bottom Line

Plexus has shifted toward higher-complexity markets like healthcare and defense to drive its revenue growth. This focus on specialized manufacturing and global scale allows the company to manage complex supply chains for its partners.